Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|25|2946-2957

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.25, 2009-09, pp. : 2946-2957

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs in Development for Viral Hepatitis: Care and Caution

By Pockros Paul J.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 263-271

Adis International

Access to resources Recommend Favorite

Development of Infection and Inflammation Targeting Compounds

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 1, 2008-01 ,pp. : 42-48

Bentham Science Publishers

Access to resources Recommend Favorite

The Rationale and Development of New Drugs to Treat HIV Infection

By  

Medicinal Chemistry, Vol. 1, Iss. 6, 2005-11 ,pp. : 635-642

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections

By Zhang Xiaoyong   Kraft Anke   Broering Ruth   Schlaak Joerg F   Dittmer Ulf   Lu Mengji  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 7, 2012-07 ,pp. : 597-611

Informa Healthcare

Access to resources Recommend Favorite

Anti-Viral Therapies for Hepatitis C Virus Infection: Current Options and Evolving Candidate Drugs

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 150-161

Bentham Science Publishers

Access to resources Recommend Favorite